BioAtla, Inc. Business Operations Contracts & Agreements
6 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (1)
- Services Agreements (1)
- Voting Agreements (1)
- Master Clinical Trial Collaboration Agreement, dated January 5, 2022, by and between BioAtla, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 4, 2022)
- China Clinical Trial Services Agreement, dated April 8, 2022, by and between BioAtla, Inc. and Himalaya Therapeutics Limited Company (Filed With SEC on August 9, 2022)
- Amendment No. 3 to Global Co-Development and Collaboration Agreement between BioAtla, Inc. and BeiGene, Ltd (Filed With SEC on February 28, 2022)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on December 8, 2020)
- Voting Agreement, dated July 13, 2020 (Filed With SEC on December 8, 2020)
- Global Co-Development and Collaboration Agreement with BeiGene, Ltd. and BeiGene Switzerland GmbH, dated April 8, 2019, as amended by First Amendment, dated December 24, 2019 and... (Filed With SEC on November 13, 2020)